Clinical Trial Update: A Phase I/II Study of Mitoxantrone Liposome Combined With Chidamide in Relapsed/Refractory Peripheral T-cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating mitoxantrone liposome with chidamide for relapsed/refractory peripheral T-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)
• Mitoxantrone Liposome (mitoxantrone liposome)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Relapsed and Refractory Peripheral T-cell Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN